课题基金 / 基金详情

RADIOPHARMACEUTICAL AND CHEMOTHERAPY TREATMENT OF METASTATIC PHEOCHROMOCYTOMA

RADIOPHARMACEUTICAL AND CHEMOTHERAPY TREATMENT OF METASTATIC PHEOCHROMOCYTOMA
转移性嗜铬细胞瘤的放射药物和化疗治疗
批准号：
6244566
负责人：
JAMES C SISSON
金额：
$2.22万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-02-20 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6244566
关键词：
clinical research combination cancer therapy cyclophosphamide dacarbazine human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer radionuclide therapy neoplasm /cancer remission /regression pheochromocytoma vincristine

项目摘要

项目成果

JAMES C SISSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose a more vigorous treatment of malignant pheochromocytomas using two approaches that have shown promise: 131-I metaiodobenzylguanidine (131-I MIBG) and three-agent chemotherapy. The goal is to attain complete remissions in 30% of treated patients. Innovation is combining sequentially two different types of therapy for a cancer that has resisted previous treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NATURE OF STUNNING OF THYROID TISSUE
RADIOIODINE TREATMENT AND GRAVES' EYE DISEASE
NATURE OF STUNNING OF THYROID TISSUE
Radioiodine Treatment and Graves' Eye Disease
海外基金